logo

Shariah compliance overview

Not Halal

Climb Bio, Inc. (CLYM) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).

About Climb Bio, Inc.

Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic solutions for inflammatory diseases driven by autoimmune responses. Its primary investigational asset is budoprutug, an anti-CD19 monoclonal antibody.

Climb Bio, Inc. (CLYM) operates in the Healthcare sector, in the Biotechnology industry.

Why it is not classified as halal: it does not pass these screens: Business Activity, Interest-bearing securities and assets.

Business Activity
100.00%Limit 5%Fail
Interest-bearing debt
0.09%Limit 30%Pass
Interest-bearing securities and assets
36.00%Limit 30%Fail
Dividend purification
100.00%Share of dividends to give to charityPurification calculator

Last updated: Oct 22, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.

Please login to access this content

Key stats

Please login to access this content

Please login to access this content

Company Profile

Please login to access this content

Frequently asked questions

Quick answers about Climb Bio, Inc. (CLYM). Current Akinda screening label: Not Halal.